| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.6 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | 0.043 | 0.6 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.032 | 0.6 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | 0.04 | 0.6 |